GC2402 Study Site 111 — Cordova, Tennessee

GC2402 Study Site 111 is a clinical research site located in Cordova, Tennessee, United States 38018.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2402 Study Site 111 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Sponsors: Grifols Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cordova

Browse all research sites in Tennessee · View every site in Cordova

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2402 Study Site 111?

GC2402 Study Site 111 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2402 Study Site 111 conducted?

GC2402 Study Site 111 has 1 clinical trials on record, with 1 currently active. Their work covers CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Is GC2402 Study Site 111 accredited by Crixeo Clinical Trials?

GC2402 Study Site 111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2402 Study Site 111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.